Source Post
3 High Growth Stocks That Are Down Big - Are They Buys Now?
Nov 26, 2025
Daniel Pronk discusses HIMS stock, noting its historical volatility and recent ~40% drawdown. He previously owned and sold HIMS for an 80% gain, citing deteriorating fundamentals. While recent earnings show strong year-over-year growth in revenue, cash flow, and subscribers, the stock sold off. Pronk highlights the increasing adoption of personalized treatment plans, which he believes makes subscribers stickier and less prone to churn.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.